Skip to main content

MGP INGREDIENTS INC

For the period ended Sep 30, 2025. Filed Oct 29, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Oct 29, 2025

MGPI$17.12-0.5%Stored close · as of Oct 30, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Income (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Dollars in thousands, except share and per share amounts)

Quarter Ended September 30,Year to Date Ended September 30,
2025202420252024
Sales$130,912$161,461$398,059$522,829
Cost of sales81,47995,646246,909310,987
Gross profit49,43365,815151,150211,842
Advertising and promotion expenses6,6919,64721,77629,995
Selling, general, and administrative expenses18,92617,20463,28760,942
Impairment of long-lived assets and other———137
Change in fair value of contingent consideration2,8006,40025,50015,900
Operating income21,01632,56440,587104,868
Interest expense, net(1,739)(2,174)(5,490)(6,398)
Other income, net4281,0269571,917
Income before income taxes19,70531,41636,054100,387
Income tax expense4,2767,5549,25523,924
Net income15,42923,86226,79976,463
Net loss (income) attributable to noncontrolling interest(7)4325162
Net income attributable to MGP Ingredients, Inc.15,42223,90526,82476,625
Income attributable to participating securities(190)(257)(322)(828)
Net income used in earnings per common share calculation$15,232$23,648$26,502$75,797
Weighted average common shares
Basic21,373,30022,069,88521,359,05122,110,315
Diluted21,373,30022,069,88521,359,05122,110,315
Earnings per common share
Basic$0.71$1.07$1.24$3.43
Diluted$0.71$1.07$1.24$3.43
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.